OR7E10P

Across TCGA pan-cancer cohorts, OR7E10P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated OR7E10P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher OR7E10P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E10P expression acts as an unfavorable survival marker, although some lineages such as TGCT and SKCM show a favorable association.

UCS, BRCA, and UVM are the cancer types where OR7E10P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	IV	0.132	0.718	.002	108	view →
BRCA	OS	Tertile	All	0.484	0.590	<.001	102	view →
UVM	OS	Tertile	II,III,IV	0.213	0.718	.002	81	view →
STAD	DFS	Quartile	All	0.508	0.765	<.001	54	view →
UCEC	OS	Tertile	IV	0.254	0.607	.007	54	view →
ACC	DFS	Tertile	All	0.193	0.659	.004	45	view →
READ	OS	Tertile	II,III,IV	0.083	0.919	<.001	39	view →
LIHC	OS	Tertile	All	0.015	0.784	<.001	36	view →
LGG	DFS	Tertile	All	0.465	0.747	<.001	33	view →
ESCA	OS	Tertile	II,III,IV	0.105	0.867	.016	18	view →
TGCT	DFS	Tertile	All	0.956	0.696	.001	18	view →
THYM	OS	Tertile	II,III,IV	0.720	0.925	.021	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

OR7E10P–UCS (DFS)

Open the UCS breakdown →